A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors

Clinical trial NCT05886075 · UNKNOWN

Trial details

NCT number: NCT05886075
Sponsor: Shanghai Yunying Medical Technology
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Lung Cancer Bronchial Cancer Non Small Cell Lung Cancer Small Cell Lung Cancer Sarcoma Colorectal Cancer Gastric Cancer Liver Cancer Breast Cancer Pancreatic Cancer Head and Neck Cancer Ovarian Cancer

Start date: 2023-03-30
Primary completion: 2025-03-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.